Details for New Drug Application (NDA): 203883
✉ Email this page to a colleague
The generic ingredient in ADENOSINE is adenosine. There are twenty-six drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the adenosine profile page.
Summary for 203883
Tradename: | ADENOSINE |
Applicant: | Hospira |
Ingredient: | adenosine |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 203883
Mechanism of Action | Adenosine Receptor Agonists |
Medical Subject Heading (MeSH) Categories for 203883
Suppliers and Packaging for NDA: 203883
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ADENOSINE | adenosine | SOLUTION;INTRAVENOUS | 203883 | ANDA | HF Acquisition Co LLC, DBA HealthFirst | 51662-1345 | 51662-1345-1 | 1 VIAL, SINGLE-DOSE in 1 CARTON (51662-1345-1) / 20 mL in 1 VIAL, SINGLE-DOSE |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 60MG/20ML (3MG/ML) | ||||
Approval Date: | Mar 24, 2014 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;INTRAVENOUS | Strength | 90MG/30ML (3MG/ML) | ||||
Approval Date: | Mar 24, 2014 | TE: | RLD: | No |
Complete Access Available with Subscription